The understanding of the molecular pathogenesis of thyroid cancers paved the way for the development of novel cutting-edge therapeutic agents; for this reason, a more tailored disease management will be possible.Thyroid cancer is the most prevalent neoplasm among endocrine tumors, presenting an increasing incidence trend over the last few years. Multikinase inhibitors have shown improved clinical outcome and implemented tumor response in advanced thyroid cancer. Cancer is still an enigmatic, complex, heterogeneous, rapidly evolving, rapidly shifting, fast adapting and unfortunately not completely understood enemy.
Targeted agents for advanced thyroid cancer: "knowledge is power"- the role of multikinase inhibitors
DIONIGI, GIANLORENZO
2014-01-01
Abstract
The understanding of the molecular pathogenesis of thyroid cancers paved the way for the development of novel cutting-edge therapeutic agents; for this reason, a more tailored disease management will be possible.Thyroid cancer is the most prevalent neoplasm among endocrine tumors, presenting an increasing incidence trend over the last few years. Multikinase inhibitors have shown improved clinical outcome and implemented tumor response in advanced thyroid cancer. Cancer is still an enigmatic, complex, heterogeneous, rapidly evolving, rapidly shifting, fast adapting and unfortunately not completely understood enemy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
